Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$53.58 - $57.02 $1,607 - $1,710
-30 Reduced 0.56%
5,296 $297,000
Q1 2024

Apr 17, 2024

SELL
$42.56 - $59.82 $97,036 - $136,389
-2,280 Reduced 29.98%
5,326 $300,000
Q4 2023

Jan 12, 2024

SELL
$32.18 - $46.57 $127,175 - $184,044
-3,952 Reduced 34.19%
7,606 $341,000
Q3 2023

Oct 11, 2023

BUY
$44.2 - $50.2 $34,520 - $39,206
781 Added 7.25%
11,558 $526,000
Q2 2023

Jul 12, 2023

BUY
$31.86 - $67.26 $19,339 - $40,826
607 Added 5.97%
10,777 $467,000
Q1 2023

Apr 25, 2023

SELL
$45.44 - $74.26 $108,101 - $176,664
-2,379 Reduced 18.96%
10,170 $668,000
Q4 2022

Jan 27, 2023

BUY
$41.39 - $81.0 $143,706 - $281,232
3,472 Added 38.25%
12,549 $564,000
Q3 2022

Oct 28, 2022

BUY
$72.36 - $113.1 $10,202 - $15,947
141 Added 1.58%
9,077 $657,000
Q2 2022

Jul 22, 2022

BUY
$87.2 - $114.05 $32,089 - $41,970
368 Added 4.3%
8,936 $959,000
Q1 2022

Apr 29, 2022

SELL
$94.19 - $124.49 $4,332 - $5,726
-46 Reduced 0.53%
8,568 $950,000
Q4 2021

Feb 01, 2022

BUY
$119.57 - $139.07 $32,044 - $37,270
268 Added 3.21%
8,614 $1.1 Million
Q3 2021

Oct 18, 2021

SELL
$109.17 - $142.35 $5,895 - $7,686
-54 Reduced 0.64%
8,346 $1.11 Million
Q2 2021

Aug 10, 2021

BUY
$100.34 - $115.69 $77,763 - $89,659
775 Added 10.16%
8,400 $908,000
Q1 2021

Apr 14, 2021

BUY
$101.51 - $125.27 $199,162 - $245,779
1,962 Added 34.65%
7,625 $803,000
Q4 2020

Jan 27, 2021

SELL
$85.88 - $105.36 $143,333 - $175,845
-1,669 Reduced 22.76%
5,663 $589,000
Q3 2020

Oct 26, 2020

SELL
$72.74 - $92.5 $9,310 - $11,840
-128 Reduced 1.72%
7,332 $628,000
Q2 2020

Aug 05, 2020

SELL
$48.02 - $79.04 $47,539 - $78,249
-990 Reduced 11.72%
7,460 $547,000
Q1 2020

Apr 14, 2020

BUY
$36.95 - $62.95 $67,433 - $114,883
1,825 Added 27.55%
8,450 $439,000
Q4 2019

Jan 31, 2020

BUY
$47.06 - $56.64 $55,201 - $66,438
1,173 Added 21.52%
6,625 $373,000
Q3 2019

Oct 17, 2019

SELL
$47.45 - $58.05 $11,672 - $14,280
-246 Reduced 4.32%
5,452 $260,000
Q2 2019

Jul 26, 2019

BUY
$39.26 - $54.21 $6,674 - $9,215
170 Added 3.08%
5,698 $309,000
Q1 2019

Apr 15, 2019

BUY
$29.84 - $43.92 $27,691 - $40,757
928 Added 20.17%
5,528 $224,000
Q4 2018

Jan 28, 2019

BUY
$29.95 - $46.34 $16,861 - $26,089
563 Added 13.95%
4,600 $143,000
Q3 2018

Oct 10, 2018

SELL
$40.12 - $45.55 $20,862 - $23,686
-520 Reduced 11.41%
4,037 $169,000
Q2 2018

Jul 31, 2018

BUY
$38.72 - $42.52 $17,075 - $18,751
441 Added 10.71%
4,557 $191,000
Q1 2018

Apr 20, 2018

BUY
$39.4 - $47.39 $13,868 - $16,681
352 Added 9.35%
4,116 $169,000
Q4 2017

Jan 18, 2018

BUY
$37.27 - $43.02 $49,308 - $56,915
1,323 Added 54.2%
3,764 $155,000
Q3 2017

Oct 25, 2017

BUY
$33.75 - $41.67 $82,383 - $101,716
2,441
2,441 $97,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track First Bank & Trust Portfolio

Follow First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.